Accelerate Diagnostics, Inc.
AXDX · NASDAQ
12/31/2024 | 9/30/2024 | 6/30/2024 | 3/31/2024 | |
|---|---|---|---|---|
| Revenue | $2,816 | $2,975 | $2,986 | $2,921 |
| % Growth | -5.3% | -0.4% | 2.2% | – |
| Cost of Goods Sold | $2,367 | $2,119 | $2,310 | $2,198 |
| Gross Profit | $449 | $856 | $676 | $723 |
| % Margin | 15.9% | 28.8% | 22.6% | 24.8% |
| R&D Expenses | $3,774 | $3,838 | $3,903 | $5,173 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4,605 | $5,636 | $5,379 | $5,706 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $0 | $13 | $0 |
| Operating Expenses | $8,381 | $9,474 | $9,282 | $10,879 |
| Operating Income | -$7,932 | -$8,618 | -$8,606 | -$10,156 |
| % Margin | -281.7% | -289.7% | -288.2% | -347.7% |
| Other Income/Exp. Net | -$1,723 | -$6,021 | -$2,982 | -$4,074 |
| Pre-Tax Income | -$9,655 | -$14,639 | -$11,588 | -$14,230 |
| Tax Expense | -$66 | $0 | $0 | $0 |
| Net Income | -$9,589 | -$14,639 | -$11,588 | -$14,230 |
| % Margin | -340.5% | -492.1% | -388.1% | -487.2% |
| EPS | -0.38 | -0.59 | -0.5 | -0.74 |
| % Growth | 35.6% | -18% | 32.4% | – |
| EPS Diluted | -0.38 | -0.59 | -0.5 | -0.74 |
| Weighted Avg Shares Out | 23,302 | 24,915 | 23,058 | 19,216 |
| Weighted Avg Shares Out Dil | 23,302 | 24,915 | 23,058 | 19,216 |
| Supplemental Information | – | – | – | – |
| Interest Income | $208 | $179 | $116 | $200 |
| Interest Expense | $4,485 | $3,593 | $2,589 | $2,450 |
| Depreciation & Amortization | $808 | $878 | $877 | $858 |
| EBITDA | -$4,362 | -$10,168 | -$8,122 | -$10,922 |
| % Margin | -154.9% | -341.8% | -272% | -373.9% |